In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lichen Planopilaris, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.

US matches:

• Hydroxychloroquine
• Hydroxychloroquine Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BA02

CAS registry number (Chemical Abstracts Service)

0000118-42-3

Chemical Formula

C18-H26-Cl-N3-O

Molecular Weight

336

Therapeutic Categories

Antiprotozoal agent: Antimalarial

Disease-modifying antirheumatic drug, DMARD

Chemical Name

Etanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]etylamino]-

Foreign Names

• Hydroxychloroquinum (Latin)
• Hydroxychloroquin (German)
• Hydroxychloroquine (French)
• Hidroxicloroquina (Spanish)

Generic Names

• Hydroxychloroquine (OS: BAN)
• Idroxiclorochina (OS: DCIT)
• Oxychloroquine (IS)
• Win 1258-2 (IS)
• Hydroxychloroquine (PH: Ph. Eur. 9.3)
• Hydroxychloroquine Sulfate (OS: BANM, JAN)
• Hydroxychloroquine Sulfate (PH: BP 2018, Ph. Eur. 9.3, USP 41)
• Hydroxychloroquini sulfas (PH: Ph. Eur. 9.3)

Brand Names

• Axokine
  Rontag, Argentina
• Dimard
  Metlen, Ecuador
• Hidroxiplus
  Perulab, Peru
• Hydrocad
  Cadila, India
• Hydroquin
  Sun Pharma, Thailand
• Ilinol
  Pharma Investi de Chile, Chile
• Mcqs
  Molekule, India
• Narbon
  Buxton, Argentina
• Plaquenil
  Concordia Pharmaceuticals, United States; Sanofi Aventis, Tunisia
• Plaquinol
  Sanofi-Aventis, Peru
• Polireumin
  Perulab, Peru
• Quinilen
  Royal Pharma, Chile
• Quinoric
  Bristol Laboratories, Cyprus; Sanolabor, Slovenia
• Reumaquin
  AC Farma, Peru
• Supretic
  Eticos, Paraguay
• Zy-Q
  Zydus, India
• APO-Hydroxychloroquine
  Apotex, Australia
• Apo-Hydroxychloroquine Sulfate
  Apotex, Hong Kong
• Apo-Hydroxyquine
  Apotex, Canada
• Be-easy
  Shinlon, Taiwan
• Chloguin
  Weidar, Taiwan
• Dimard
  Siegfried, Colombia
• Dolquine
  Rubio, Spain
• Evoquin
  Ivax, Argentina; Teva, Uruguay
• Fen Le
  ZhongXi Pharmaceutical, China
• Geniquin
  Genovate, Taiwan
• Haloxin
  Hanlim, South Korea
• HCQS
  IPCA, Thailand
• Hequinel
  Arrow Pharmaceuticals, Australia
• Hidroxicloroquina Sulfato Pharma Arte
  Pharma Arte, Paraguay
• Hydroquine
  Minapharm, Egypt; Taiwan Biotech, Taiwan
• Hydroxychloroquine
  Apotex, Russian Federation
• Hydroxychloroquine AN
  Amneal Pharma, Australia
• Hydroxychloroquine GH
  Generic Health, Australia
• Hydroxychloroquine RBX
  Ranbaxy, Australia
• Hydroxychloroquine sulfate
  Zentiva, United Kingdom
• Hydroxychloroquine Sulfate
  Hikma, United States; Ipca, United States; Mylan, United States; Sandoz, United States; Teva, United States; Watson Pharmaceutical, United States; Zydus Pharma, United States
• Hydroxychloroquine Sulfate Lenis
  LENIS, Slovenia
• Hydroxychloroquine Sulphate P & D
  P & D, Malta
• Hydroxychloroquine Zentiva 200mg
  Helvepharm, Switzerland
• Hydroxychloroquinesulfaat CF
  Centrafarm, Netherlands
• Metirel
  Pfizer, Uruguay; Rontag, Argentina
• Mylan-Hydroxychloroquine
  Mylan Pharmaceuticals, Canada
• Oxiklorin
  Kyung Poong, South Korea; Orion Pharma, Finland
• Plaquenil
  Abbott Laboratories S.A., China; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; First Pharma, Estonia; Lex ano, Lithuania; Sanofi, Denmark; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, China; Sanofi Belgium, Belgium; Sanofi Israel, Israel; Sanofi Malta, Malta; Sanofi Romania, Romania; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Canada; Sanofi-Aventis, Cyprus; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Philippines; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Aventis SA, Greece; synth, Egypt
• Plaquenil 200mg
  Sanofi Belgium, Luxembourg; Sanofi-Aventis, Switzerland
• Plaquenil-Hydroxychloroquine sulfate
  Zentiva, United Kingdom
• Plaquinol
  Alfa Wassermann, Portugal; Sanofi Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Farmaceutica, Brazil
• Polirreumin
  TRB Pharma, Argentina
• Pro-Hydroxyquine
  Pro Doc, Canada
• Quensyl 200mg
  Sanofi-Aventis Deutschland, Germany
• Quinoric
  Bristol Laboratories, United Kingdom; Central Procurement & Supplies Unit, Malta
• Reumazine
  Instituto Sanitas, Chile
• Reuquinol
  Apsen, Brazil

Glossary

Further information on drug naming conventions: International Nonproprietary Names.